|Articles|February 1, 1997

February 1997
Volume 3
Issue 2

Should Managed Care Organizations Pay for Nicotine Replacement Therapy?

Author(s)Eric C. Westman, MD, MHS

Download PDF: Should Managed Care Organizations Pay for Nicotine Replacement Therapy?

Articles in this issue

about 29 years ago

Article

A Successful Tobacco Cessation Program Led by Primary Care Nurses in a Managed Care Setting

about 29 years ago

Article

Outcomes of Routine Testing of Liver Enzymes in Institutionalized Geriatric Patients

about 29 years ago

Article

The Influence of Day of Life in Predicting the Inpatient Costs for Providing Care to Very Low Birth Weight Infants

about 29 years ago

Article

The Three Dimensions of Managed Care Pharmacy Practice

about 29 years ago

Article

Alternative Insurance Arrangements and the Treatment of Depressions: What are the Facts?

about 29 years ago

Article

Use of PRISM Scores in Triage of Pediatric Patients with Diabetic Ketoacidosis

about 29 years ago

Article

Short-Term Continuous Infusion Thrombolytic Therapy for Occluded Central Venous Dialysis Catheters

about 29 years ago

Article

Primary Gonadotropin-Releasing Hormone Agonist Therapy for Suspected Endometriosis: A Nonsurgical Approach to the Diagnosis and Treatment of Chronic Pelvic Pain

about 29 years ago

Article

Prepaid Capitation Versus Fee-for-Service Reimbursement in a Medicaid Population

about 29 years ago

Article

Hospitals and Managed Care: Catching Up with the Networks

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Should Managed Care Organizations Pay for Nicotine Replacement Therapy?

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD